Voiant Acquires Voxeleron to Expand with AI Technology

April 15, 2025 – Voiant, a leader in clinical trial imaging solutions, today is announcing the acquisition of Voxeleron, a pioneering company in AI-driven ophthalmic image analysis. This strategic acquisition marks a significant advancement in Voiant’s mission to accelerate the development of innovative treatments for eye diseases. Voiant’s extensive ophthalmic clinical trial expertise coupled with… Read more »

FIECON Joins Herspiegel to Expand Commercialization Services

YARDLEY, Pa. and LONDON, April 7, 2025 /PRNewswire/ — Herspiegel, a world leader in pharmaceutical and biotech commercialization services, continues its strategic expansion by joining forces with FIECON, Europe’s leading health economics and market access consultancy firm. This strategic integration expands Herspiegel’s proven market access capabilities and enhances Herspiegel’s global footprint. The integrated global access services will support patient access… Read more »

AQUALIS Acquires Stormwater Compliance Solutions, LLC

MORRISVILLE, N.C.- AQUALIS, the nation’s leading provider of sustainable water management, engineering and compliance services for critical infrastructure, announced today it has acquired the assets of Stormwater Compliance Solutions, LLC (SCS). Headquartered in Chester, N.J. with a second office in the Greater Denver area, Stormwater Compliance Solutions has been performing stormwater inspections, maintenance and compliance… Read more »

DFW Named a Top 50 PE Firm for Executives For Third Year

CLEVELAND, OH. – March 12, 2025   PrivateEquityCXO and Falcon Partners have announced 2025’s Top 50 Private Equity Firms who best enable their portfolio company executives to drive maximum returns. Winners are determined through data collected from thousands of sponsor-backed executives highlighting their experiences and rating funds using PE-CXO’s Nine Dimensions of Governance Fit®, a… Read more »

FDA Approves MUDELLA®, from Sebela Women’s Health Inc.

FDA Approves MIUDELLA®, the First Hormone-Free Copper Intrauterine System (IUS) in the U.S. in Over 40 Years, from Sebela Women’s Health Inc. ROSWELL, GA, February 24, 2025 – Sebela Women’s Health Inc., a part of Sebela Pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) granted approval of MIUDELLA® (copper intrauterine system) for… Read more »

Saol Therapeutics announces acceptance of New Drug Application

ROSWELL, Ga, DUBLIN and HAMILTON, Bermuda, Jan. 28, 2025 — Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SL1009, Sodium Dichloroacetate Oral Solution (DCA).  DCA will be used with a proprietary genetic test to treat an orphan pediatric mitochondrial disease, Pyruvate… Read more »

VertexOne Acquires Accelerated Innovations

DALLAS, TX — December 16, 2024 — VertexOne, a leading provider of cloud software designed to revolutionize the customer experience within the energy and utility industry, announced today the completed acquisition of Accelerated Innovations LLC (AI), a top-tier provider of essential customer self-service and engagement solutions to utilities, known for its state-of-the-art MyMeter platform.  MyMeter, developed from deep expertise in the electric utility industry, delivers indispensable digital SaaS solutions for influencing customer… Read more »

Saol Therapeutics Announces Submission of New Drug Application

ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, Dec. 3, 2024 /PRNewswire/ — Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of SL1009, Sodium Dichloroacetate Oral Solution (DCA) for use with a proprietary genetic test, for the treatment of an orphan pediatric mitochondrial disease,… Read more »

Vantage Insurance Partners, Inc. Appoints Jack Butcher as CEO to Drive Next Phase of Growth

Oct. 30, 2024  — Vantage Insurance Partners, Inc., a rapidly expanding insurance brokerage and risk management consulting firm, announced the appointment of Jack Butcher as Chief Executive Officer, succeeding Alex Panlilio. With a robust background in leading growth focused organizations through M&A, operational excellence and innovation, Mr. Butcher will lead Vantage forward as it enters its new… Read more »

DFW Capital Partners Closes Investment in B&A

August 27th, 2024 – DFW Capital Partners (“DFW”) announced today that it has completed an investment in B&A (the “Company”). Headquartered in McLean, Virginia, B&A is a leading information technology systems integrator on behalf of government agencies. This partnership represents a bold step forward for B&A, with DFW’s capabilities and resources enabling the next stage… Read more »